Skip to main content

This job has expired

You will need to login before you can apply for a job.

R&D Bispecific Antibodies Researcher

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, New York, United States of America
Start date
Jul 10, 2021

View more

Job Details

Get to know the Bispecific Antibody and Cell Therapy team at Regeneron Pharmaceuticals as we work towards deploying the immune system to fight cancer. Support our ongoing efforts to design, engineer and characterize next-generation protein-based and cell-based therapies. Effort will encompass multiple therapeutic areas such as oncology, auto-immune disease, infectious disease, muscle/metabolism and neurosciences in our state-of-the-art research facility. Work closely with a talented, highly innovative team of Scientists both within the group and across the organization to develop our novel technologies and advance therapeutics into the clinic to benefit patients.

If you want to work on exciting projects such as these, please submit your resume today! The team is seeking experience with one or more of the skills listed below:
• Perform molecular biology and biochemical techniques involving DNA and Protein characterization
• Conduct protein structure-based analysis and design
• Mammalian cell culture using primary and established cell lines
• Cell processing and expansion of T cell cultures
• Perform protein expression and protein purification
• Characterization of conventional and novel antibody formats using in-vitro methodologies, such as flow cytometry and immunoassays with human immune cells
• Perform in vivo efficacy studies in mice

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert